Equity Analysis /
United States of America

US : Regeneron Pharmaceuticals, Inc. - REGN | REGN5458 Data Update, and the New Targets on the R/R MM Block

    Dane Leone
    Bowen Wu
    Bowen Wu

    Res. Assoc.

    CGS-CIMB
    12 December 2021
    Published by